Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Smoflipid vs Intralipid 20% in Pediatric Parenteral Nutrition
NCT03563222Phase 4Terminated
- Sponsor
- Fresenius Kabi
- Start
- Dec 2019
- Primary completion
- Nov 2020
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of SMOFlipid in Malnutrition, sponsored by Fresenius Kabi. Started Dec 2019; status: terminated.
02
Drugs
SMOFlipid
03
Conditions
Malnutrition
Beyond the preview
Go deeper on NCT03563222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03563222.